An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for purchases.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is worrisome and could result in users injecting products of unknown origin.
Some professionals stated the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Response and Material Removal
According to the social media company, the service has removed violative material and banned related keywords and search suggestions. The company stated it was committed to maintaining the service safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of slimming results, positive reviews and detailed guides for mixing or administering at residence.
Within minutes of joining one group, a vendor shared contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Item Information and Pricing
Within these communities, messages show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are administering substances they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has already encountered individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to potentially serious medical dangers”.
